Overview

Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements

Status:
Completed
Trial end date:
2019-04-15
Target enrollment:
Participant gender:
Summary
A double-blind within-subject study to estimate observed application site adverse events following topical applications of crisaborole and vehicle in healthy participants
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer